Executive summary
A brief overview of the NHS’s overall vulnerability to fraud, bribery and corruption.
- For 2025 - 26, the amount of NHS funding vulnerable to loss through fraud, bribery, and corruption in England is
estimated to be £1.301bn, a reduction of £45.06m compared with the SIA 2025.
- This equates to 0.66% of the Total Managed Expenditure for the NHS for 2025 - 2026 of £198.095bna , a decrease
compared to the previous year.
- The NHSCFA received 8,048 reports in 2025 - 26, with 7,645 aligning to the main thematic areas,
showing an
increase of almost 19% when compared with 2024 - 2025.
- The areas which received the highest number of reports were NHS staff fraud, patient exemption fraud,
procurement and commissioning fraud, and fraudulent access to NHS care from overseas visitors,
accounting for
approximately 84% of reporting.
- The five highest financial vulnerabilities are procurement and commissioning fraud (£442.7m), patient exemption
fraud (£268.76m), pharmaceutical contractor fraud (£138.49m), GP contractor fraud (£114.41m) and
fraudulent access to NHS care from overseas visitors (£96.5m).
- Regional reporting remains highest in London, the Midlands and the North East and Yorkshire,
indicating a
continued concentration of reporting in areas with high population density.
- The NHSCFA’s approach towards being an intelligence-led organisation has been improved over the last few years,
as we now analyse fraud at local, regional and national level, both strategically and tactically, allowing for
the allocation of resourcing based on demand, including for emerging and prevalent trends.
- Overall, the assessment shows a reduction in estimated financial vulnerability alongside rising
reporting
volumes, suggesting a continued need for focused prevention and enforcement activity.
Financial vulnerability estimates by Thematic area, 2025 to 2026 compared with 2024 to 2025
| Procurement and commissioning fraud |
£442.7m |
£392.5m |
£50.2m |
665 |
| Patient exemption fraud |
£268.76m |
£230.2m |
£38.56m |
1820 |
| Pharmaceutical contractor fraud |
£138.49m |
£135.2m |
£3.31m |
297 |
| GP contractor fraud |
£114.41m |
£116.7m |
-£2.27m |
222 |
| Fraudulent access to NHS care from overseas visitors |
£96.5m |
£98.1m |
-£1.58m |
544 |
| Optical contractor fraud |
£91.22m |
£90.7m |
£0.57m |
45 |
| Data manipulation fraud |
£57.36m |
£189.1m |
-£131.69m |
14 |
| Dental contractor fraud |
£56.96m |
£57.6m |
£-0.62m |
176 |
| NHS staff fraud |
£28.17m |
£27.8m |
£0.41m |
3753 |
| NHS bursary fraud |
£3.69m |
£3.8m |
-£0.12m |
23 |
| NHS pension fraud |
£2.09m |
£4.1m |
-£2.01m |
74 |
| Reciprocal healthcare fraud |
£0.99m |
£0.8m |
£0.17m |
12 |
| £1.301bn |
£1.346bn |
-£45.06m |
7645c |